At booth #115, Integer will spotlight its latest advancements in neuromodulation and next-generation miniaturized active ...
For individuals with major depressive disorder (MDD) that does not respond to pharmacotherapy, recent decisions by the U.S.
Given the growing interest in non-invasive neuromodulation devices for the central nervous system, the Forum on Neuroscience and Nervous System Disorders hosted a public workshop on March 2-3, 2015 to ...
ProlivRx therapy scales physician-directed brain neuromodulation beyond the clinic into the homeCORAL SPRINGS, Fla., Jan. 12, 2026 /PRNewswire/ -- Neurolief Inc., a medical device company focused ...
When most people consider treatment for psychiatric problems, they usually consider medications and/or psychotherapy. However, emerging neuromodulation approaches using transcranial magnetic ...
The clinical trial is expected to enroll up to 40 patients in two stages: an initial open-label pilot (10 patients) followed by a randomized, double-blinded, sham-controlled trial (30 patients).
BrainsWay’s strategic investment in Neurolief paved the way for the first and only FDA approved at-home neuromodulation ...
Data presented at CTAD showed strong separation from placebo and statistical significance in mild-to-moderate patients on key global, cognitive, and behavioral measures including CDR-SB, ADAS- Cog 11 ...
The US Food and Drug Administration (FDA) has granted 510 (k) clearance for BlueWind Medical, Ltd.’s enhanced Revi® implantable tibial neuromodulator for treatment of urgency urinary incontinence (UUI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback